Review article · 2026 · Open access

Considerations for the Integration of Clinical Trials and Real‐World Data

Shawn Qiu, Charles E. Barr, Lauren Dang, Larry Han, Kajsa Kvist, Hana Lee, Andrew Mertens, Nerissa Nance, Lei Nie, Kara E. Rudolph, Xu Shi, Jens M. Tarp and 8 more

Clinical Pharmacology & Therapeutics · Published 5 October 2026 · DOI 10.1002/cpt.70513

Open PDFView at the publisherCite this paper

In brief

“Considerations for the Integration of Clinical Trials and Real‐World Data” is a 2026 review article by Shawn Qiu and 19 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 2 citations as of 16 November 2026, which puts it in the top 5% of works published in 2026 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
1.21
References
59
Authors
20

Abstract

As clinical decision-making increasingly moves toward individualized and context-specific treatment recommendations, reliance on any single evidence source, randomized or observational, may be insufficient. Principled integration of randomized controlled trials and real-world data, grounded in explicit causal frameworks, offers a path toward evidence that is both internally credible and externally relevant. In this article, we describe distinct objectives for the integration of randomized controlled trials and real-world data and discuss how these objectives shape key design and analytic considerations, illustrating the resulting choices through example estimands. We highlight practical issues that commonly arise in applied settings, including data relevance and curation, cross-source comparability, estimand specification, and sensitivity analysis. We aim for this article to help readers evaluate and implement principled approaches to integrating randomized controlled trials and real-world data in ways that can support more reliable treatment recommendations while maintaining regulatory-grade evidentiary standards.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Qiu, S., Barr, C. E., Dang, L., Han, L., Kvist, K., Lee, H., Mertens, A., Nance, N., Nie, L., Rudolph, K. E., Shi, X., Tarp, J. M., Waddy, S. P., Wiley, K., Wilson, A., Yann, M. L.-J., Zhang, Z., Zhou, T., Petersen, M., & van der Laan, M. J. (2026). Considerations for the Integration of Clinical Trials and Real‐World Data. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70513

MLA 9

Qiu, Shawn, et al. “Considerations for the Integration of Clinical Trials and Real‐World Data.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70513.

Chicago

Qiu, Shawn, Charles E. Barr, Lauren Dang, Larry Han, Kajsa Kvist, Hana Lee, Andrew Mertens, et al. 2026. “Considerations for the Integration of Clinical Trials and Real‐World Data.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70513.

Harvard

Qiu, S. et al. (2026) ‘Considerations for the Integration of Clinical Trials and Real‐World Data’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70513.

IEEE

S. Qiu et al., “Considerations for the Integration of Clinical Trials and Real‐World Data,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70513.

BibTeX

@article{qiu2026considerations,
  title     = {{Considerations for the Integration of Clinical Trials and Real‐World Data}},
  author    = {Qiu, Shawn and Barr, Charles E. and Dang, Lauren and Han, Larry and Kvist, Kajsa and Lee, Hana and Mertens, Andrew and Nance, Nerissa and Nie, Lei and Rudolph, Kara E. and Shi, Xu and Tarp, Jens M. and Waddy, Salina P. and Wiley, Kenneth and Wilson, Andy and Yann, Margot Lisa-Jing and Zhang, Zhiwei and Zhou, Tianyue and Petersen, Maya and van der Laan, Mark J.},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2026},
  doi       = {10.1002/cpt.70513},
  url       = {https://doi.org/10.1002/cpt.70513}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques

  • estimands
  • causal framework
  • personalized treatment
  • generalizability
  • data comparability
  • sensitivity analysis
  • data curation
  • treatment guidelines

Work with this paper

Most-cited papers in Mathematics

All highly cited Mathematics papers

Questions about this paper

How do I cite this paper in APA style?

Qiu, S., Barr, C. E., Dang, L., Han, L., Kvist, K., Lee, H., Mertens, A., Nance, N., Nie, L., Rudolph, K. E., Shi, X., Tarp, J. M., Waddy, S. P., Wiley, K., Wilson, A., Yann, M. L.-J., Zhang, Z., Zhou, T., Petersen, M., & van der Laan, M. J. (2026). Considerations for the Integration of Clinical Trials and Real‐World Data. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70513

How many times has this paper been cited?

2 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

Shawn Qiu, Charles E. Barr, Lauren Dang, Larry Han, Kajsa Kvist, Hana Lee, Andrew Mertens, Nerissa Nance, Lei Nie, Kara E. Rudolph, Xu Shi, Jens M. Tarp and 8 more.

What is the DOI of this paper?

10.1002/cpt.70513, permanently at https://doi.org/10.1002/cpt.70513. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.